When was Arctoris founded?

Arctoris was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is Arctoris located?

Arctoris is headquartered in Abingdon, United Kingdom. It is registered at 9400 GARSINGTON ROAD,OXFORD BUSINESS PARK,OXFORD,UNITED KINGDOM,OX4 2HN.

Who is the current CEO of Arctoris?

Thomas A Fleming of Arctoris. They have also founded 1 company.

Which legal entities is Arctoris associated with?

Arctoris is associated with Arctoris Ltd.

How many employees does Arctoris have?

As of Feb 28, 2025, the latest employee count at Arctoris is 37.

Is Arctoris a funded company?

Arctoris is a funded company, having raised a total of $3.93M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 30, 2019.

When was the latest funding round of Arctoris?

Arctoris' latest funding was a $***** Seed round on Nov 19, 2020, with participation from 1 investor.

Where does Arctoris rank among its competitors?

Arctoris ranks 11th amongst 820 active competitors, of which 55 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of Arctoris?

Arctoris' top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

Arctoris - 2026 Company Profile, Team, Funding, Competitors & Financials

Arctoris is a seed company based in Abingdon (United Kingdom), founded in 2016 by Kilian R Dinkelaker, Marti Immanuel Bittner and Thomas A Fleming. It operates as a Provider of automated wet lab biology research and data generation services. Arctoris has raised $3.93M in funding from RT. The company has 820 active competitors, including 55 funded and 49 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.

Company Details

Provider of automated wet lab biology research and data generation services. This organization operates a robotic, cloud-controlled discovery platform to run assay cascades across biochemistry, biophysics, cell biology, and structural biology. It combines robotics, data science, and biological expertise to generate experimental data for drug discovery. The platform captures parameters and datapoints in real time to produce reproducible datasets.

Website: www.arctoris.com/
Social
Email ID: *****@arctoris.com
Phone Number: +44 **********
Registered Address: 9400 GARSINGTON ROAD,OXFORD BUSINESS PARK,OXFORD,UNITED KINGDOM,OX4 2HN

Key Metrics

Founded Year

2016

Location

Abingdon, United Kingdom

Stage

Seed

Total Funding

$3.93M in 2 rounds

Latest Funding Round

Seed, Nov 19, 2020, $*****

Investors

RT & 8 more

Ranked

11^th among 820 active competitors

Employee Count

37 as on Feb 28, 2025

Similar Companies

Alloy Therapeutics & 841 more

View Arctoris' full profile

Arctoris is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Arctoris Ltd CIN: 9987028 , United Kingdom, Active	Feb 03, 2016	-	37 (As on Feb 28, 2025)

Arctoris has raised a total funding of $3.93M over 2 rounds. Its first funding round was on Sep 30, 2019. Its latest funding round was a Seed round on Nov 19, 2020 for $*****. 1 investor participated in its latest round. Arctoris has 5 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Arctoris:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 19, 2020	9581131	Seed	9570408	6266683	4363604	8627272
Sep 30, 2019	3895062	Seed	4878479	6185403	RT & 2 more	Tanarra & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Arctoris's funding rounds and investors

The founders of Arctoris are Kilian R Dinkelaker, Marti Immanuel Bittner and Thomas A Fleming. Thomas A Fleming is the CEO of Arctoris.

Here are the details of Arctoris' key team members:

Kilian R Dinkelaker: Former Co-Founder of Arctoris.
Marti Immanuel Bittner: Former Co-Founder of Arctoris.
Thomas A Fleming: Co-Founder & CEO of Arctoris.
Contact Info: 2 email addresses

View details of Arctoris's Founder profiles and Board Members

Arctoris' employee count trend

Arctoris has 37 employees as of Feb 25. Here is Arctoris's employee count trend over the years:

Uncover Arctoris' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Arctoris include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Arctoris, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Triatomic, Playground Global & 8 others	58/100
5th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	53/100
6th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Panacea Venture, Shunwei Capital & 17 others	53/100
7th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Bpifrance & 5 others	52/100
8th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	52/100
9th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	50/100
10th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Spinnotec, Temasek & 3 others	51/100
11th	Arctoris 2016, Abingdon (United Kingdom), Seed	Provider of automated wet lab biology research and data generation services	$3.93M	TD Veen, Tanarra & 7 others	51/100